Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.
Grégoire BoivineauCamille ZallotFranck ZerbibLaurianne PlastarasAurélien AmiotLucile BoivineauStéphane KochLaurent Peyrin-BirouletLucine VuittonPublished in: Journal of Crohn's & colitis (2022)
This is the first multicentre cohort study showing that half of patients treated with anti-TNF therapy for MC achieved clinical remission in case of budesonide failure.